Cannes Contenders: FCB Interface

How will Asia Pacific perform at Cannes this year? In the lead up to the Festival, Campaign Brief Asia will be showcasing the work we hope will impress the judges...

Speed of Ejaculation Racehorse Orgasm.jpgKamaSutra Super Thin: Speed of Ejaculation: Racehorse Orgasm/Speed of Ejaculation: Greyhound Orgasm
FCB Interface

The brief to launch KamaSutra Super Thin condoms. The idea, in India, the pull-out method is the most preferred contraceptive among couples. Because a lot of Indians are allergic to the 'latex' feel. However, this is a highly unreliable method of contraception!

By dramatising the unreliability of the pull out method Kamasutra offers a solution ++ SuperThin condoms that protect, without the latex feel!
Speed of Ejaculation Greyhound Orgasm.jpg

We are inviting agencies to showcase your agency's best chances at Cannes this year. Open to all Asian based agencies entering Cannes this year. Just email with a paragraph or two on each of your best chances at this year's festival. Include a link to the case study/TVC or supply jpegs if it is print.   

Leave a comment

About Campaign Brief Asia

A blog for advertising creatives in Asia. To pass on news or advertise on the CB Asia blog, or to subscribe to Campaign Brief Asia or Campaign Brief Australia/NZ magazines, or The Work 09 Annual, email: Kim or Michael

Latest jobs

Retrieving latest jobs

House rules for commenting

Here are the ground rules for posting comments on stories: This site is a moderated blog. Comments that are seen to be more abusive than witty and/or constructive will not be posted. Obviously, we do not allow 'hate speech' or comments that are seen as a personal attack, defamatory, degrading or prejudicial to an individual or company. Overly abusive language also adds nothing to any discussion and will not be published. On occasions we will be asking people to contribute work, opinions and views on various topics - you are free to disagree, so long as you observe the above rules and remain constructive.